Catatan episode
Hunt, Jason, and Mike walk the Cash Flow Memo through $90 oil that will not change oil-patch spending, a compute market sold out through 2028, and a healthcare desk that still found time for Eliquis.
The Cashflow Memo
Key Takeaways
* Hunt’s $70-$90 oil range still holds at the top - crude is ~$90 and he does not see it running much higher - but Iran’s infeasible demands (US bases out, Hormuz cargo tolls, reparations, sanctions off) keep him closer to 90 than 80 for 6-12 months; ~20 ships/day still move (Iraqi crude allowed, Saudis can go Red Sea), producers still underwrite $70-75 so activity does not spike, and $90 oil maps to roughly $4.00-$4.20 US gasoline.
* Industrial read-through is Caterpillar: data-center turbines plus reshoring and data-center construction more than offset lagging housing, and Hunt says tariffs, $90 oil, and the political noise are not changing what they hold or add; Mike wants more macro time on these calls now that Warsh is detoxifying Fed guidance.
* Compute demand is still exponential: Jassy says AWS AI is sold out through 2026-27 and most of 2028, $200B of CapEx this year still will not close it, and recursive learning models by year-end are another multiple of inference per user - Hunt prefers Amazon, Google, and Microsoft as the compute owners and cannot make up his mind on Meta.
* Supply cannot catch that demand in ’27-’28: New York’s >200 MW hold, Virginia saturation, and the Texas governor’s ERCOT audit all push off-grid; combined cycle is 3-4 years out, simple turbines (GE, Cat, Siemens) are sold out, SpaceX Memphis (~$30B, 2 GW, 1-1.5 year payout to Anthropic and Google, 4-5 GW ambition by end-’27) is the exception; Hunt would avoid CoreWeave even after it extended 2020 A100s through 2029 at a 25% price hike.
* Chip and memory bottlenecks sit behind the power constraint - TSMC wafers plus packaging, Intel closer on packaging than lithography, memory prices hitting Apple - and Tesla/SpaceX’s Terafab is a first-principles end-run around ASML (particle-accelerator EUV vs tin-droplet lasers) that Huawei is already pursuing; healthcare: FDA closes the GRAS food-ingredient loophole, the childhood vaccine schedule goes 17 to 11 diseases (Japan’s MMR split was reversed after completion collapsed), Thermo Fisher is seeing early-stage equipment rebound, and the AZN-BMY rumor died even as Eliquis (one-third of BMY sales, largest Medicare Part D line) faces a 2028 patent cliff that Jason puts at ~$10B of Part D savings.
Show Notes
[00:00] Intro & Cash Flow Memo Download the memo at telltales.us; 30 minutes on energy, technology, and healthcare cash flows.
[00:27] Iran, Hormuz, and $90 Oil Iran’s demands are not negotiable, so Hunt keeps oil closer to $90 than $80 for 6–12 months. About 20 ships a day still move; Iraqi crude is allowed through, and Saudi barrels can go Red Sea.
[04:20] $70 Decisions and Caterpillar Producers still underwrite $70–75, so activity does not spike. Caterpillar is the industrial read-through…
Situs: telltales.substack.com

